Cite
MLA Citation
P Emery et al.. “P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study.” Annals of the rheumatic diseases, vol. 77, n.d., p. A52. http://access.bl.uk/ark:/81055/vdc_100136586087.0x000057